Robert Charles Breedlove, Principal Accounting Officer at Phathom Pharmaceuticals, Inc. (PHAT), sold 461 shares at $12.09 ($6K) on 2025-09-05, disclosed to the SEC on 2025-09-09.
Open-market sale of $6k PHAT by Principal Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |